Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma

NCT: NCT05764954 · ACTIVE_NOT_RECRUITING

NCT IDNCT05764954
StatusACTIVE_NOT_RECRUITING
Start Date2023-08-04
Completion2027-08

Brief Summary

The researchers are doing this study to find out if treatment with TTFields using the NovoTTF-200T System is safe and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatment may help the body's immune system to fight cancer.

Frequently Asked Questions

What is A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma?

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma is a clinical trial registered under NCT05764954. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05764954?

The current status of NCT05764954 (A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma) is: ACTIVE_NOT_RECRUITING.

When did A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma start?

A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma started on 2023-08-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑